MedicarePartD.guide

A non-government resource built from CMS public data

Selarsdi on HealthSpring Assurance Rx (S5617-220)

ustekinumab-aekn

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 0.5 per 28 days.

$472.75
Patient pays / month, after deductible
$952.45
Patient pays / month, before the $615.00 deductible
$1,418.25
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

SELARSDI 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $2,148.87 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
SELARSDI 45 mg/.5mL Injection, Solution3$472.75PA · 0.5 per 28 days
SELARSDI 45 mg/.5mL Injection, Solution3$472.75PA · 0.5 per 28 days
SELARSDI 90 mg/mL Injection, Solution5$994.85PA · 1 per 28 days

Other IL-17 and IL-23 biologics on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-220